Value of human chorionic gonadotropin compared to CEA in discriminating benign from malignant effusions.

Lamerz, R; Stoetzer, O J; Mezger, J; Brandt, A; Darsow, M; Wilmanns, W

Lamerz, R; Stoetzer, O J; Mezger, J; Brandt, A; Darsow, M; Wilmanns, W.

Affiliation

Lamerz R; Medical Department II, Klinikum Grosshadern, University of Munich, Germany. lamerz@med2.med.uni-muenchen.de

Anticancer Res ; 19(4A): 2421-5, 1999.

Article in En | MEDLINE | ID: mdl-10470169

Subject(s)

Biomarkers, Tumor/analysis; Carcinoembryonic Antigen/analysis; Chorionic Gonadotropin/analysis; Exudates and Transudates/chemistry; Neoplasms/diagnosis; Biomarkers, Tumor/blood; Carcinoembryonic Antigen/blood; Chorionic Gonadotropin/blood; Diagnosis, Differential; Female; Gastrointestinal Diseases/blood; Gastrointestinal Diseases/diagnosis; Humans; Kidney Diseases/blood; Kidney Diseases/diagnosis; Male; Neoplasms/blood; Neoplasms/physiopathology; ROC Curve; Sensitivity and Specificity

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Carcinoembryonic Antigen / Biomarkers, Tumor / Exudates and Transudates / Chorionic Gonadotropin / Neoplasms Type of study: Diagnostic_studies / Prognostic_studies Limits: Female / Humans / Male Language: En Journal: Anticancer Res Year: 1999 Document type: Article Affiliation country: Germany

Search on Google

Add to My VHL

XML

PubMed Links